Insulin-like Growth Factor-1 Receptor Inhibitor class drugs
1 result
Tepezza (teprotumumab)
(teprotumumab)Horizon Therapeutics USA, Inc.
Usage: TEPEZZA is indicated for the treatment of Thyroid Eye Disease, applicable to all patients regardless of the disease's activity or duration.